<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03362801</url>
  </required_header>
  <id_info>
    <org_study_id>SAMPHYR 16-181.</org_study_id>
    <nct_id>NCT03362801</nct_id>
  </id_info>
  <brief_title>SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly</brief_title>
  <acronym>SAMPHYR</acronym>
  <official_title>SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia is associated with lower prognosis in solid tumors, but this has not been studied&#xD;
      in bladder carcinoma requiring cystectomy.&#xD;
&#xD;
      According to EWGSOP recommendations, the diagnosis of sarcopenia is based on walking speed,&#xD;
      grip strength and muscle mass. These three elements can easily be measured (specially muscle&#xD;
      mass measurement by bioimpedencemetry or tomodensitometry).&#xD;
&#xD;
      This cohort study will collect clinical complementary elements to better understand the&#xD;
      associated factors present with sarcopenia, in order to prepare an interventional&#xD;
      preoperative physical reconditioning study.&#xD;
&#xD;
      The mobility measurement will be carried out by the QAPPA questionnaire (validated in French&#xD;
      in the elderly) and the quantitative measurement of activity and rest hours during a week by&#xD;
      a wrist actimeter.&#xD;
&#xD;
      Standardized geriatric data will also be collected: ADL, IADL for autonomy, MMSE for&#xD;
      cognitive status, nutritional status (% weight loss, BMI), pain, GDS15 for depression&#xD;
      screening, updated Charlson Comorbidity Index to identify polypathology and The STOPP tool&#xD;
      for potentially inappropriate medication.&#xD;
&#xD;
      Post-operative morbidity mortality at 30 days will be evaluated according to Clavien-Dindo&#xD;
      classification. Investigators will also evaluate 6 months geriatric complications : falls,&#xD;
      loss of autonomy and decreased mobility and physical activity, cognitive degradation,&#xD;
      undernutrition, institutionalization&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-operative morbidity</measure>
    <time_frame>at 30 days</time_frame>
    <description>evaluated according to Clavien-Dindo classification</description>
  </primary_outcome>
  <primary_outcome>
    <measure>post-operative mortality</measure>
    <time_frame>at 30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>Impact of dependancy (PS / ADL / IADL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>physical activity scores (QAPPA) Questionnaire d'activité physique pour les personnes âgées in French validated in French population - total score is used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>physical performance (PBP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>fatigue (BFI) Brief Fatigue Inventory questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>history of fall</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>pain (visual analogic scale for pain 0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>hours of mobility (actimetry)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>hours of daily rest (actimetry) measured during 3 consecutives days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>Actimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>nutritional status (nutritional grade 2 or 4 according to SFNEP Société Francophone Nutrition Clinique et Métabolisme )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>cognitive status (normal or not)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>polymedication (≥5 / day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>comorbidities (updated charlson)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications</measure>
    <time_frame>8 months</time_frame>
    <description>inappropriate prescriptions (STOPP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impedancemetric value</measure>
    <time_frame>2 months</time_frame>
    <description>Concordance of values (attribution of sarcopenic / non-sarcopenic groups) with impedancemetric value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sarcopenic status</measure>
    <time_frame>between baseline; preoperative and at 6 months post-operative</time_frame>
    <description>evolution of sarcopenic status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life scores</measure>
    <time_frame>preoperative and 6-month post-operative</time_frame>
    <description>EORTC QLQ-ELD14 (assessment of health-related quality of life elderly patients with cancer with 14 items)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">69</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Sarcopenic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>sarcopenic status the day before cystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>not sarcopenic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>sarcopenic status the day before cystectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>sarcopenia and mobility measurement</intervention_name>
    <description>walking speed, grip strength and BIA. QAPPA questionnaire (validated in French in the elderly) and the objective measurement of the time of activity and rest on a week per wrist actimeter.&#xD;
Comprehensive Geriatric Assessment</description>
    <arm_group_label>Sarcopenic</arm_group_label>
    <arm_group_label>not sarcopenic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  confirmed urothelial bladder carcinoma ( RTUV)&#xD;
&#xD;
               -  indication of radical cystectomy&#xD;
&#xD;
               -  Able, informed and with informed consent for the study&#xD;
&#xD;
               -  affiliated to the social security system&#xD;
&#xD;
               -  talking French&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life expectancy &lt;6 months&#xD;
&#xD;
               -  other active malignant tumors or other severe concomitant chronic pathologies&#xD;
                  affecting the general condition of the patient and / or likely to limit&#xD;
                  compliance with the requirements of the study.&#xD;
&#xD;
               -  treatments incompatible with the study: previous corticosteroid treatment&#xD;
                  prolonged for more than one month (induces iatrogenic sarcopenia).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>françois fournel</last_name>
    <phone>+33231065488</phone>
    <email>fournel-f@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>helene legros</last_name>
    <email>legros-h@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bérengère Beauplet, PhD</last_name>
      <email>beauplet-b@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilie Nouzergues</last_name>
      <email>Emilie.NOUGUEREDE@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Laure Couderc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rouen UH</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maeva Bizon</last_name>
      <email>Maeva.Bizon@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Christian Pfister</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Audisio RA, Bozzetti F, Gennari R, Jaklitsch MT, Koperna T, Longo WE, Wiggers T, Zbar AP. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer. 2004 May;40(7):926-38.</citation>
    <PMID>15093567</PMID>
  </results_reference>
  <results_reference>
    <citation>Huisman MG, van Leeuwen BL, Ugolini G, Montroni I, Spiliotis J, Stabilini C, de'Liguori Carino N, Farinella E, de Bock GH, Audisio RA. &quot;Timed Up &amp; Go&quot;: a screening tool for predicting 30-day morbidity in onco-geriatric surgical patients? A multicenter cohort study. PLoS One. 2014 Jan 24;9(1):e86863. doi: 10.1371/journal.pone.0086863. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103907. de'Liguori Carino, Nicola [corrected to Carino, Nicola de'Liguori]. PLoS One. 2016;11(1):e0147993.</citation>
    <PMID>24475186</PMID>
  </results_reference>
  <results_reference>
    <citation>Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer. 2016 Apr;57:58-67. doi: 10.1016/j.ejca.2015.12.030. Epub 2016 Feb 13. Review.</citation>
    <PMID>26882087</PMID>
  </results_reference>
  <results_reference>
    <citation>Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, Stewart SB, Thapa P, Tarrell RF, Cheville JC, Tollefson MK. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014 Sep 15;120(18):2910-8. doi: 10.1002/cncr.28798. Epub 2014 May 19.</citation>
    <PMID>24840856</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, Woods ME, Muss H, Nielsen ME. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol. 2014 Jun;191(6):1714-20. doi: 10.1016/j.juro.2013.12.047. Epub 2014 Jan 11.</citation>
    <PMID>24423437</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>November 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>physical activity</keyword>
  <keyword>elderly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

